Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Miller

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
BMC Neurology|March 25, 2021
Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosisEfrat Neter, Lea Glass-Marmor, Anat Wolkowitz, et al.
Circulation Research|April 20, 2002
Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenationYaara Ben-Yosef, Nitza Lahat, Sarah Shapiro, et al.
Annals of Neurology|June 24, 2008
Impact of exposure to war stress on exacerbations of multiple sclerosisDaniel Golan, Eli Somer, Sara Dishon, et al.
Neurology|July 28, 2016
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosisDaniel Golan, Ariel Miller, Elias S Sotirchos, et al.
Plos One|July 16, 2014
Gene expression profiling of the response to interferon beta in Epstein-Barr-transformed and primary B cells of patients with multiple sclerosisRana Khsheibun, Tamar Paperna, Anat Volkowich, et al.
Scientific Reports|June 21, 2026
Aging with multiple sclerosis and associated prevalence, incidence, comorbidities and healthcare utilization patterns in a population based studyElsebeth Staun-Ram, Efrat Neter, Lea Glass-Marmor, et al.
Clinical Neurology and Neurosurgery|June 5, 2004
Bio-markers of disease activity and response to therapy in multiple sclerosisAriel Miller, Lea Glass-Marmor, Michal Abraham, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
Patients with multiple sclerosis in a war zone: coping strategies associated with reduced risk for relapseEli Somer, Daniel Golan, Sara Dishon, et al.
Journal of Cellular Biochemistry|March 6, 2012
The ubiquitin-proteasome pathway regulates claudin 5 degradationIlana Mandel, Tamar Paperna, Anat Volkowich, et al.
Journal of Neuroimmunology|November 6, 2002
Inorganic lead enhances cytokine-induced elevation of matrix metalloproteinase MMP-9 expression in glial cellsNitza Lahat, Sarah Shapiro, Paul Froom, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
BMC Neurology|March 25, 2021
Beliefs about medication as predictors of medication adherence in a prospective cohort study among persons with multiple sclerosisEfrat Neter, Lea Glass-Marmor, Anat Wolkowitz, et al.
Circulation Research|April 20, 2002
Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenationYaara Ben-Yosef, Nitza Lahat, Sarah Shapiro, et al.
Annals of Neurology|June 24, 2008
Impact of exposure to war stress on exacerbations of multiple sclerosisDaniel Golan, Eli Somer, Sara Dishon, et al.
Neurology|July 28, 2016
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosisDaniel Golan, Ariel Miller, Elias S Sotirchos, et al.
Plos One|July 16, 2014
Gene expression profiling of the response to interferon beta in Epstein-Barr-transformed and primary B cells of patients with multiple sclerosisRana Khsheibun, Tamar Paperna, Anat Volkowich, et al.
Scientific Reports|June 21, 2026
Aging with multiple sclerosis and associated prevalence, incidence, comorbidities and healthcare utilization patterns in a population based studyElsebeth Staun-Ram, Efrat Neter, Lea Glass-Marmor, et al.
Clinical Neurology and Neurosurgery|June 5, 2004
Bio-markers of disease activity and response to therapy in multiple sclerosisAriel Miller, Lea Glass-Marmor, Michal Abraham, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
Patients with multiple sclerosis in a war zone: coping strategies associated with reduced risk for relapseEli Somer, Daniel Golan, Sara Dishon, et al.
Journal of Cellular Biochemistry|March 6, 2012
The ubiquitin-proteasome pathway regulates claudin 5 degradationIlana Mandel, Tamar Paperna, Anat Volkowich, et al.
Journal of Neuroimmunology|November 6, 2002
Inorganic lead enhances cytokine-induced elevation of matrix metalloproteinase MMP-9 expression in glial cellsNitza Lahat, Sarah Shapiro, Paul Froom, et al.
Pageof 11